Cytokinetics

YTD

ALL

Trade Cytokinetics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

CEO

Robert I. Blum

CEORobert I. Blum

Employees

673

Employees673

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

1997

Founded1997

Employees

673

Employees673

CYTK Key Statistics

Market cap

10.23B

Market cap10.23B

Price-Earnings ratio

-12.40

Price-Earnings ratio-12.40

Dividend yield

—

Dividend yield—

Average volume

2.78M

Average volume2.78M

High today

$85.20

High today$85.20

Low today

$80.90

Low today$80.90

Open price

$83.45

Open price$83.45

Volume

1.89M

Volume1.89M

52 Week high

$88.31

52 Week high$88.31

52 Week low

$32.89

52 Week low$32.89

Stock Snapshot

Cytokinetics(CYTK) stock is priced at $82.14, giving the company a market capitalization of 10.23B. It carries a P/E multiple of -12.40.

As of 2026-07-13, Cytokinetics(CYTK) stock has fluctuated between $80.90 and $85.20. The current price stands at $82.14, placing the stock +1.5% above today's low and -3.6% off the high.

The Cytokinetics(CYTK)'s current trading volume is 1.89M, compared to an average daily volume of 2.78M.

In the last year, Cytokinetics(CYTK) shares hit a 52-week high of $88.31 and a 52-week low of $32.89.

CYTK News

Simply Wall St 2d

How Myqorzo’s US and German Launches Will Impact Cytokinetics Investors - simplywall.st

...

TipRanks 2d

Larimar, Cytokinetics, Itau, Global-e, Immunovant Shake-Up

Insiders have been trading these 5 stocks: ((LRMR)), ((CYTK)), ((ITUB)), ((GLBE)) and ((IMVT)). Here is a breakdown of their recent trades and their value. Tip...

TipRanks 6d

High-Profile Insider Trade Shakes Up Cytokinetics Watchlist

New insider activity at Cytokinetics ( (CYTK) ) has taken place on July 7, 2026. 4th of July Sale - 70% Off Unlock powerful investing tools and data-driven insi...

Analyst ratings

91%

of 22 ratings

Buy

90.9%

Hold

9.1%

Sell

More CYTK News

TipRanks 6d

Cytokinetics price target lowered to $117 from $119 at RBC Capital

RBC Capital analyst Leonid Timashev lowered the firm’s price target on Cytokinetics (CYTK) to $117 from $119 and keeps an Outperform rating on the shares as par...

People also own

Based on the portfolios of people who own CYTK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.